Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
2020 · Cell · 487 citations
https://doi.org/10.1016/j.cell.2020.04.020
L
Leiping Zeng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
2.4K
Citations
12
h-index
12
i10-index
Leiping Zeng is an academic researcher from Stanford University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Immune Cell Function and Interaction & Cytomegalovirus and herpesvirus research. The author has an h-index of 12, co-authored 24 publications.
ORCID: 0000-0002-6421-0950Papers by this author
worksBroad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
2022 · Nature Communications · 46 citations
https://doi.org/10.1038/s41467-022-30546-7
Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection
2022 · Cell Reports Methods · 25 citations
https://doi.org/10.1016/j.crmeth.2022.100170
Additional file 4 of Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19135919
Additional file 6 of Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19135928
Additional file 7 of Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19135931
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat